UNCATEGORIZED

29 Aug 2022 · Paul Langley

Podcast - IR Department talks to Race Oncology's CSO Dr Daniel Tillett

Interview with Race Oncology’s CSO Dr Daniel Tillett

Read article
NEWSLETTER SEPT 2022

29 Aug 2022 · Paul Langley

Mosquito-borne diseases in Australia - an interview with Dr David Foster, CEO of Island Pharmaceuticals

We speak with Dr David Foster, CEO & Managing Director of Island Pharmaceuticals, about the current mosquito-borne diseases landscape in Australia. With recent outbreaks of dengue fever and Japane...

Read article
NEWSLETTER SEPT 2022

29 Aug 2022 · Paul Langley

Kazia Therapeutics CEO Dr James Garner talks with SmallCaps about what's on the horizon

Kazia Therapeutics (ASX: KZA) CEO James Garner joins Small Caps to discuss the company’s ongoing development of its lead drug paxalisib, which recently generated positive interim data in a phase one…

Read article
NEWSLETTER SEPT 2022

29 Aug 2022 · Paul Langley

Interview with Assoc.Prof. Mathias Francois of Gertrude Biomedical

We talk to Associate Professor Mathias Francois of Gertrude Biomedical, world-leaders in small molecular inhibitors to SOX18, a unique drug target with significant commercial and clinical potential

Read article
NEWSLETTER SEPT 2022

29 Aug 2022 · Paul Langley

HaemaLogiX's Tertia Dex explains the KappaMab antibody

HaemaLogix's Chief Manufacturing and Development Officer, Tertia Dex, explains the fascinating process to manufacture KappaMab, a highly-targeted antibody designed to treat mutliple myeloma.

Read article
NEWSLETTER SEPT 2022

04 Jul 2022 · Cherie Hartley

Podcast - IR Department talks with AdAlta CEO & MD, Dr Tim Oldham

Interview with AdAlta’s CEO & Managing Director Dr Tim Oldham

Read article
UNCATEGORIZED

31 Mar 2022 · Paul Langley

IRD Invest March 2022 - Pureprofile

IRD Invest 31st March 2022 - "Project: 2025"

Read article
UNCATEGORIZED

31 Mar 2022 · Paul Langley

IRD Invest March 2022 - Oventus

IRD Invest 31st March 2022 - "Project: 2025"

Read article
UNCATEGORIZED

31 Mar 2022 · Paul Langley

IRD Invest March 2022 - Openpay

IRD Invest March 2022 - "Project: 2025"

Read article
NEWSLETTER MARCH 2022

25 Mar 2022 · Michael Lovesey

Register now for our next IRD Invest virtual investor conference, where emerging tech companies will talk about the tailwinds driving their businesses

Join our investor conference on 31 March – Technology focused virtual event!

Read article